Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 3 Results

Title
Intervention Indication Therapeutic Area Year Actions
Triheptanoin for long-chain fatty acid oxidation disorders Triheptanoin (UX007; Dojolvi) Long chain fatty acid oxidation disorders (LC-FAOD) Endocrine Nutritional and Metabolic Disorders 2021 View  |  Download
Triheptanoin for long chain fatty acid oxidation disorders Triheptanoin (UX007; Dojolvi) Long chain fatty acid oxidation disorders (LC-FAOD) Endocrine Nutritional and Metabolic Disorders 2020 View  |  Download
Triheptanoin (UX-007) for glucose transporter type 1 deficiency syndrome (de vivo disease) – first line Triheptanoin (UX007; Dojolvi) Glucose transporter type 1 deficiency syndrome Endocrine Nutritional and Metabolic Disorders 2017 View  |  Download
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications